A path plagued by progression: The chronic kidney disease journey
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
As therapies become increasingly complex and personalized, it is imperative that physicians...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
Today’s most innovative companies are leveraging digital health data solutions to deliver...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Lab Data in Clinical Research: 4 Ways It Drives Better Outcomes While most life sciences teams know...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic inflammatory bowel disease that affects about 1.5 million individuals in North America.1 Once considered a condition primarily seen in people of European ances...